<DOC>
	<DOCNO>NCT00653900</DOCNO>
	<brief_summary>A large number patient currently Antiplatelet inhibition use aspirin Plavix therapy ( A Thieno pyridine - ADP mediate platelet inhibitor ) . A group patient often require Cardiac and/or Vascular surgical procedure . These patient high risk perioperative bleed complication higher re-operation/re-exploration bleed subsequent blood product transfusion . The aim protocol assess platelet function via `` Verify Now '' device prior surgery . The Verify Now device require small drop fresh blood sample FDA approve device . Our initial goal establish certain degree platelet function abnormality predict high bleed complication high transfusion ( Phase I , 20 patient ) . This initial study allow u determine sample size Phase II . Phase II maintain protocol , however completion Phase I , accurate sample size determination make . Additionally , want establish knowledge platelet dysfunction change procedure technique preparation lower bleeding and/or lead cancellation/rescheduling procedure ( Phase III ) . Participants patient take plavix undergoing vascular cardiac surgery . They undergo platelet function evaluation measure Platelet Response Unit ( PRU ) via `` verify '' device admission/pre surgery . This test involve take 1 drop blood patient , one time , procedure . The Verify Now device FDA approve . Perioperative bleeding assess absolute drop hematocrit immediate post-op compare immediate preoperative value . An additional discharge hematocrit use blood product use initial hospital stay . Hematocrit evaluation via complete blood count part standard patient care . Additionally , utilization blood product ( factor , PLT , PRBC 's , etc . ) assess . In order conduct research , patient identify review OR schedule . All consecutive patient ASA/Plavix mail letter order introduce study . The letter provide phone number call patient NOT want receive phone call investigative staff . This letter uploaded item 18-02 study application . If patient call office , investigative staff call potential participant introduce study . Final consent complete PACU arrival hospital plan surgical procedure . A Hematocrit perform consent patient preoperatively , immediately post-op , discharge . A PRU assess use drops patient ' blood preoperatively ( PACU ) . Patients ' record review assess use blood product . No additional follow require . Patients ' care different current standard care , 1 `` verify '' test , do procedure .</brief_summary>
	<brief_title>Platelet Function Testing Help Intraoperative Bleeding Risk Patients Who Are Plavix Prior Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>All consent participant take plavix prior undergo vascular cardiac surgery . All consent participant NOT take plavix prior undergo vascular cardiac surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Verify</keyword>
	<keyword>platelet function</keyword>
	<keyword>platelet function test</keyword>
	<keyword>bleeding risk</keyword>
	<keyword>periprocedural bleeding</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>Our initial goal establish certain degree</keyword>
	<keyword>platelet function abnormality predict high bleeding</keyword>
	<keyword>high transfusion .</keyword>
</DOC>